120 related articles for article (PubMed ID: 19125313)
1. Immunosuppressive activity of mesenchymal stem cells is not decreased in children with aplastic anemia.
Xu Y; Takahashi Y; Yoshimi A; Tanaka M; Yagasaki H; Kojima S
Int J Hematol; 2009 Jan; 89(1):126-127. PubMed ID: 19125313
[No Abstract] [Full Text] [Related]
2. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.
Bueno C; Roldan M; Anguita E; Romero-Moya D; Martín-Antonio B; Rosu-Myles M; del Cañizo C; Campos F; García R; Gómez-Casares M; Fuster JL; Jurado M; Delgado M; Menendez P
Haematologica; 2014 Jul; 99(7):1168-75. PubMed ID: 24727813
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk.
Fattizzo B; Giannotta JA; Barcellini W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751628
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia.
Xu Y; Takahashi Y; Wang Y; Hama A; Nishio N; Muramatsu H; Tanaka M; Yoshida N; Villalobos IB; Yagasaki H; Kojima S
Exp Hematol; 2009 Dec; 37(12):1393-9. PubMed ID: 19772889
[TBL] [Abstract][Full Text] [Related]
5. Increased apoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymal stem cells in severe aplastic anemia.
Chao YH; Lin CW; Pan HH; Yang SF; Weng TF; Peng CT; Wu KH
Pediatr Blood Cancer; 2018 Sep; 65(9):e27247. PubMed ID: 29870142
[TBL] [Abstract][Full Text] [Related]
6. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Doney K; Leisenring W; Storb R; Appelbaum FR
Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
[TBL] [Abstract][Full Text] [Related]
8. [Effect of antilymphocytic globulin on immunologic parameters in children with acquired aplastic anemia].
Nikitin DO; Gavrilova LV
Gematol Transfuziol; 1992 Jan; 37(1):15-7. PubMed ID: 1618375
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia.
Liu C; Li Z; Sheng W; Fu R; Li L; Zhang T; Wu Y; Xing L; Song J; Wang H; Shao Z
Immunol Invest; 2014; 43(5):491-503. PubMed ID: 24661133
[TBL] [Abstract][Full Text] [Related]
10. Insensitive to PTH of CD8
Li S; Qin M; Wu R; Meng H; He Y; Wang B; Zhou X; Zhu G
Int J Med Sci; 2020; 17(12):1665-1672. PubMed ID: 32714069
[TBL] [Abstract][Full Text] [Related]
11. Low expression of basic fibroblastic growth factor in mesenchymal stem cells and bone marrow of children with aplastic anemia.
Jiang Sy; Xie Xt; Jiang H; Zhou Jj; Li Fx; Cao P
Pediatr Hematol Oncol; 2014 Feb; 31(1):11-9. PubMed ID: 24308692
[TBL] [Abstract][Full Text] [Related]
12. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
13. [Gene profile and fibroblast growth factor 2 expression in mesenchymal stem cell from children with aplastic anemia].
Jiang SY; Xie XT; Zhou JJ
Zhonghua Er Ke Za Zhi; 2009 Mar; 47(3):218-20. PubMed ID: 19573438
[No Abstract] [Full Text] [Related]
14. Treatment of aplastic anemia with immunosuppressive agents.
Takaku F
Tokai J Exp Clin Med; 1986; 11 Suppl():197-204. PubMed ID: 3452242
[TBL] [Abstract][Full Text] [Related]
15. [Studies of bone marrow T lymphocytes in patients with aplastic anemia].
Zeng F; Shen B; Shi Q
Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):541-3. PubMed ID: 15625832
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted characterization of the signatures and efficacy of mesenchymal stem/stromal cells in acquired aplastic anemia.
Huo J; Zhang L; Ren X; Li C; Li X; Dong P; Zheng X; Huang J; Shao Y; Ge M; Zhang J; Wang M; Nie N; Jin P; Zheng Y
Stem Cell Res Ther; 2020 Feb; 11(1):59. PubMed ID: 32054519
[TBL] [Abstract][Full Text] [Related]
17. [Biological characteristics of bone marrow-derived mesenchymal stem cells and their relationship with immunosuppressive therapy in children with aplastic anemia].
Huang YL; Huang SL; Huang K; Cai Y
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):9-13. PubMed ID: 18289461
[TBL] [Abstract][Full Text] [Related]
18. [B and T lymphocyte subpopulations in peripheral blood and bone marrow blood from aplastic anemia in childhood (author's transl)].
Nakagawa T; Yata J; Nakayama K
Rinsho Ketsueki; 1975 Sep; 16(9):850-8. PubMed ID: 175190
[No Abstract] [Full Text] [Related]
19. Effect of kidney-reinforcing, blood-activating and stasis-removing recipes on adhesion molecule expression of bone marrow mesenchymal stem cells from chronic aplastic anemia patients.
Ye B; Chen D; Wu D; Wu X; Zhang X; Zhou Y; Shen Y; Shao K; Yu QH
J Tradit Chin Med; 2012 Dec; 32(4):596-603. PubMed ID: 23427395
[TBL] [Abstract][Full Text] [Related]
20. [Colony formation of bone marrow hematopoietic progenitor cells in patients with severe aplastic anemia and its relation to the results of immunosuppressive therapy].
Xia C; Chu Y; Shao Z; Zhang J; Tang X; Tian Z; Chen G; Zhang Y; Zhang J
Zhonghua Xue Ye Xue Za Zhi; 1997 Oct; 18(10):538-40. PubMed ID: 15625831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
